Jeremy Grantham

GMO

Jeremy Grantham (GMO) is tracked through public portfolio filings, disclosed holdings, and institutional investment activity. This Jeremy Grantham (GMO) portfolio page tracks GMO holdings, stock picks, latest portfolio moves, and historical 13F filing changes so readers can see which public companies GMO owns and how disclosed positions change over time. Jeremy Grantham (GMO)'s public portfolio can help investors study position sizing, sector exposure, concentration, new buys, trims, exits, and the market themes behind reported capital allocation decisions. Top disclosed holdings and portfolio changes shown on this page include Wells Fargo & Co (WFC), Mastercard Incorporated Common Stock (MA), Netflix Inc (NFLX), Synopsys Inc (SNPS), and Elevance Health, Inc. Common Stock (ELV). Investors use GMO 13F filings to study portfolio concentration, new buys, trims, exits, sector exposure, and the market evidence behind the latest disclosed holdings.

Performance

Reported Value
$39B
Estimated Value
$43B
Estimated P/L
+$4.5B
Estimated Return
+11.9%
Priced Coverage
576/628

Performance is estimated from disclosed holdings and available market prices. It is not an official fund return.